Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VE303
VE303
Vedanta Raises $106.5M to Advance New Class of C.diff Therapeutics
BioSpace
Tue, 04/25/23 - 10:00 pm
Vedanta Biosciences
funding
C. difficile
VE303
Microbiome upstart Vedanta gets an extra $18.5M in the bank, wrapping up $45.5 series C round
Endpoints
Mon, 05/13/19 - 10:03 am
microbiome
Vedanta Biosciences
VE303
Clostridium Difficile